Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 80 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $14.724 million which missed the analyst consensus estimate of $14.740 million by 0.11 percent. This is a 15.97 percent increase over sales of $12.696 million the same period last year.